Related Experiment Video
Updated: Nov 21, 2025
05:32
Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
Published on: August 11, 2023
2.5K
[Embolic stroke of undetermined source]
O I Vinogradov1, M A Jablonskij2, A N Kuznecov1
1Pirogov National Medical and Surgical Center, Moscow, Russia.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|January 15, 2021
Summary
Cryptogenic stroke, often embolic stroke of undetermined source (ESUS), affects 20-40% of ischemic stroke survivors. Anticoagulants may offer better secondary prevention for ESUS patients than antiplatelet drugs, though specific treatments are still needed.
Area of Science:
- Neurology
- Cardiology
- Vascular Medicine
Background:
- A significant percentage of ischemic stroke survivors remain without a clear etiological classification, termed cryptogenic stroke.
- The majority of these cryptogenic strokes are presumed to be embolic in origin.
- Embolic stroke of undetermined source (ESUS) is a defined subtype, characterized by non-lacunar brain infarcts lacking identified proximal arterial stenosis or cardioembolic origins.
Purpose of the Study:
- To explore the characteristics and potential therapeutic strategies for patients diagnosed with embolic stroke of undetermined source (ESUS).
- To evaluate the potential benefits of different secondary prevention methods in ESUS patients.
Main Methods:
- Review of diagnostic evaluations for ischemic stroke survivors.
- Definition and characterization of the embolic stroke of undetermined source (ESUS) cohort.
- Comparison of potential secondary prevention strategies, including anticoagulants versus antiplatelet agents.
Main Results:
- Embolic stroke of undetermined source (ESUS) patients are typically younger with less disability and a more favorable prognosis compared to other stroke subtypes.
- Anticoagulant therapy is hypothesized to be more advantageous than antiplatelet therapy for secondary prevention in ESUS.
Conclusions:
- Embolic stroke of undetermined source (ESUS) represents a distinct clinical entity within ischemic stroke.
- Further research and development of specific treatment and secondary prevention guidelines for ESUS are warranted.
- The potential superiority of anticoagulants over antiplatelet agents in ESUS requires further investigation and clinical validation.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
123
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
123
01:29Pulmonary Embolism I: Introduction
268
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
268
01:20Imaging Studies for Cardiovascular System II:Types of Echocardiography
478
Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
478
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
118
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
118
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
125
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
125
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
166
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
166